DPDPE
Clinical data | |
---|---|
Other names | L-Tyrosyl-D-penicillamyl-glycyl-L-phenylalanyl-D-penicillamine (2->5)-disulfide; H-Tyr-D-Pen(1)-Gly-Phe-D-Pen(1)-OH |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C30H39N5O7S2 |
Molar mass | 645.79 g·mol−1 |
3D model (JSmol) | |
| |
|
DPDPE ([D-Pen2,D-Pen5]enkephalin) is a synthetic opioid peptide and a selective agonist of the δ-opioid receptor (DOR) which is used in scientific research.[1] It was developed in the early 1980s and was the first highly selective agonist of the DOR to be developed.[1] It was derived from structural modification of met-enkephalin.[2]
See also
References
- ^ a b Tseong LF (1 September 1995). Pharmacology of Opioid Peptides. CRC Press. pp. 9–. ISBN 978-3-7186-5632-5.
- ^ Kastin A, Kastin AJ (28 April 2011). Handbook of Biologically Active Peptides. Academic Press. pp. 1430–. ISBN 978-0-08-046379-7.